← All trials
NCT06834932
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 6, 2024
- Primary completion
- Jun 18, 2027
- Completion date
- Jun 18, 2027
- First posted
- Feb 19, 2025
- Last posted
- Oct 29, 2025
- Enrollment
- 300
- Arms / groups
- 8 / —
- Source
- AACT · ctgov ingestion
Sponsors
- AstraZenecaLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.